Drugs, Campagnoli (Gsk): “Mepolizumab effective in 4 pathologies with eosinophil alterations”
"Through research we have developed the monoclonal antibody mepolizumab, directed against interleukin-5, which has demonstrated its ...
Read more
Tag: Campagnoli
Editor's Choice
Latest News, World News, Breaking News, Games,Technology, Business, Lifestyle, Fashion, Sports, Food & Technology.